nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—Gefitinib—Erlotinib—pancreatic cancer	0.288	0.504	CrCrCtD
Cisapride—Metoclopramide—Sunitinib—pancreatic cancer	0.283	0.496	CrCrCtD
Cisapride—CYP2A6—Tamoxifen—pancreatic cancer	0.025	0.0663	CbGbCtD
Cisapride—KCNH2—Sunitinib—pancreatic cancer	0.0187	0.0497	CbGbCtD
Cisapride—CYP2A6—Fluorouracil—pancreatic cancer	0.0184	0.0489	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0171	0.0453	CbGbCtD
Cisapride—CYP3A7—Tamoxifen—pancreatic cancer	0.0171	0.0453	CbGbCtD
Cisapride—CYP2B6—Tamoxifen—pancreatic cancer	0.0163	0.0432	CbGbCtD
Cisapride—CYP3A7—Irinotecan—pancreatic cancer	0.0131	0.0348	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0131	0.0348	CbGbCtD
Cisapride—CYP3A5—Tamoxifen—pancreatic cancer	0.0128	0.034	CbGbCtD
Cisapride—CYP2B6—Irinotecan—pancreatic cancer	0.0125	0.0332	CbGbCtD
Cisapride—CYP2C8—Tamoxifen—pancreatic cancer	0.0123	0.0327	CbGbCtD
Cisapride—CYP1A2—Dacarbazine—pancreatic cancer	0.012	0.0318	CbGbCtD
Cisapride—CYP3A5—Erlotinib—pancreatic cancer	0.0109	0.0289	CbGbCtD
Cisapride—CYP2C8—Erlotinib—pancreatic cancer	0.0105	0.0278	CbGbCtD
Cisapride—CYP2C19—Tamoxifen—pancreatic cancer	0.0104	0.0274	CbGbCtD
Cisapride—CYP3A5—Irinotecan—pancreatic cancer	0.00985	0.0261	CbGbCtD
Cisapride—CYP3A7—Docetaxel—pancreatic cancer	0.00963	0.0255	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.00963	0.0255	CbGbCtD
Cisapride—CYP3A7—Sunitinib—pancreatic cancer	0.00958	0.0254	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00958	0.0254	CbGbCtD
Cisapride—CYP1A2—Tamoxifen—pancreatic cancer	0.00955	0.0253	CbGbCtD
Cisapride—CYP2C8—Fluorouracil—pancreatic cancer	0.00909	0.0241	CbGbCtD
Cisapride—CYP2C9—Tamoxifen—pancreatic cancer	0.00861	0.0228	CbGbCtD
Cisapride—CYP1A2—Erlotinib—pancreatic cancer	0.00812	0.0215	CbGbCtD
Cisapride—CYP2D6—Tamoxifen—pancreatic cancer	0.00787	0.0209	CbGbCtD
Cisapride—CYP3A5—Docetaxel—pancreatic cancer	0.00722	0.0191	CbGbCtD
Cisapride—CYP3A5—Sunitinib—pancreatic cancer	0.00719	0.0191	CbGbCtD
Cisapride—HTR3A—enteric nervous system—pancreatic cancer	0.00709	0.511	CbGeAlD
Cisapride—CYP1A2—Fluorouracil—pancreatic cancer	0.00704	0.0187	CbGbCtD
Cisapride—CYP2B6—Doxorubicin—pancreatic cancer	0.00683	0.0181	CbGbCtD
Cisapride—CYP2D6—Erlotinib—pancreatic cancer	0.00669	0.0177	CbGbCtD
Cisapride—CYP2C9—Fluorouracil—pancreatic cancer	0.00634	0.0168	CbGbCtD
Cisapride—CYP3A4—Tamoxifen—pancreatic cancer	0.005	0.0133	CbGbCtD
Cisapride—CYP3A4—Erlotinib—pancreatic cancer	0.00426	0.0113	CbGbCtD
Cisapride—CYP3A4—Irinotecan—pancreatic cancer	0.00384	0.0102	CbGbCtD
Cisapride—CYP2D6—Doxorubicin—pancreatic cancer	0.0033	0.00875	CbGbCtD
Cisapride—HTR2A—enteric nervous system—pancreatic cancer	0.00286	0.206	CbGeAlD
Cisapride—CYP3A4—Docetaxel—pancreatic cancer	0.00282	0.00746	CbGbCtD
Cisapride—CYP3A4—Sunitinib—pancreatic cancer	0.0028	0.00743	CbGbCtD
Cisapride—CYP3A4—Doxorubicin—pancreatic cancer	0.0021	0.00556	CbGbCtD
Cisapride—HTR3A—islet of Langerhans—pancreatic cancer	0.000677	0.0489	CbGeAlD
Cisapride—KCNH2—islet of Langerhans—pancreatic cancer	0.000408	0.0295	CbGeAlD
Cisapride—HTR3A—digestive system—pancreatic cancer	0.000407	0.0294	CbGeAlD
Cisapride—CYP3A5—islet of Langerhans—pancreatic cancer	0.000337	0.0243	CbGeAlD
Cisapride—Gefitinib—EGFR—pancreatic cancer	0.000316	1	CrCbGaD
Cisapride—HTR2B—digestive system—pancreatic cancer	0.000307	0.0222	CbGeAlD
Cisapride—CYP2C19—digestive system—pancreatic cancer	0.000257	0.0185	CbGeAlD
Cisapride—CYP3A5—pancreas—pancreatic cancer	0.000237	0.0171	CbGeAlD
Cisapride—CYP1A2—digestive system—pancreatic cancer	0.00021	0.0151	CbGeAlD
Cisapride—CYP3A5—digestive system—pancreatic cancer	0.000202	0.0146	CbGeAlD
Cisapride—CYP2B6—digestive system—pancreatic cancer	0.000201	0.0145	CbGeAlD
Cisapride—CYP2C9—digestive system—pancreatic cancer	0.000199	0.0144	CbGeAlD
Cisapride—HTR2A—digestive system—pancreatic cancer	0.000164	0.0118	CbGeAlD
Cisapride—CYP3A4—digestive system—pancreatic cancer	0.000152	0.011	CbGeAlD
Cisapride—CYP2D6—digestive system—pancreatic cancer	0.000149	0.0108	CbGeAlD
Cisapride—CYP2D6—Metabolism—CD44—pancreatic cancer	4.4e-06	0.000117	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.39e-06	0.000116	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CD44—pancreatic cancer	4.36e-06	0.000116	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—KRAS—pancreatic cancer	4.34e-06	0.000115	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—STK11—pancreatic cancer	4.31e-06	0.000114	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PPARG—pancreatic cancer	4.31e-06	0.000114	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	4.29e-06	0.000114	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.27e-06	0.000113	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TERT—pancreatic cancer	4.26e-06	0.000113	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.23e-06	0.000112	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GCG—pancreatic cancer	4.22e-06	0.000112	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NFKBIA—pancreatic cancer	4.2e-06	0.000111	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TERT—pancreatic cancer	4.19e-06	0.000111	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.19e-06	0.000111	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GCG—pancreatic cancer	4.18e-06	0.000111	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NOTCH1—pancreatic cancer	4.16e-06	0.00011	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—TYMS—pancreatic cancer	4.16e-06	0.00011	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	4.08e-06	0.000108	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CG—pancreatic cancer	4.07e-06	0.000108	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—NRAS—pancreatic cancer	4.07e-06	0.000108	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TSC2—pancreatic cancer	4.07e-06	0.000108	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.05e-06	0.000107	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EGF—pancreatic cancer	4.02e-06	0.000107	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HIF1A—pancreatic cancer	4.01e-06	0.000106	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TSC2—pancreatic cancer	4e-06	0.000106	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—APOE—pancreatic cancer	3.99e-06	0.000106	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—PIK3CA—pancreatic cancer	3.99e-06	0.000106	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.98e-06	0.000106	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—APOE—pancreatic cancer	3.98e-06	0.000106	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—STK11—pancreatic cancer	3.97e-06	0.000105	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—STK11—pancreatic cancer	3.93e-06	0.000104	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	3.93e-06	0.000104	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.92e-06	0.000104	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—APOE—pancreatic cancer	3.92e-06	0.000104	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—APOE—pancreatic cancer	3.9e-06	0.000104	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KDR—pancreatic cancer	3.9e-06	0.000103	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CB—pancreatic cancer	3.87e-06	0.000103	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KDR—pancreatic cancer	3.84e-06	0.000102	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	3.74e-06	9.91e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CD44—pancreatic cancer	3.73e-06	9.89e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.72e-06	9.86e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CXCL8—pancreatic cancer	3.71e-06	9.85e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—TYMS—pancreatic cancer	3.71e-06	9.84e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	3.71e-06	9.84e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—EGFR—pancreatic cancer	3.71e-06	9.83e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTGS2—pancreatic cancer	3.7e-06	9.82e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.69e-06	9.79e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HRAS—pancreatic cancer	3.69e-06	9.79e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	3.67e-06	9.74e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.65e-06	9.69e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NFKBIA—pancreatic cancer	3.65e-06	9.68e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.62e-06	9.6e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NOTCH1—pancreatic cancer	3.61e-06	9.58e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	3.6e-06	9.56e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	3.59e-06	9.53e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	3.59e-06	9.53e-05	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—AKT1—pancreatic cancer	3.59e-06	9.52e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CD—pancreatic cancer	3.58e-06	9.49e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GCG—pancreatic cancer	3.58e-06	9.48e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CASP3—pancreatic cancer	3.56e-06	9.43e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EGF—pancreatic cancer	3.55e-06	9.42e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.54e-06	9.4e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CG—pancreatic cancer	3.53e-06	9.37e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—NRAS—pancreatic cancer	3.53e-06	9.37e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	3.52e-06	9.34e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—KRAS—pancreatic cancer	3.5e-06	9.29e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EGF—pancreatic cancer	3.49e-06	9.26e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PPARG—pancreatic cancer	3.48e-06	9.23e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CCND1—pancreatic cancer	3.46e-06	9.18e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CTNNB1—pancreatic cancer	3.43e-06	9.09e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	3.42e-06	9.08e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—TYMS—pancreatic cancer	3.41e-06	9.05e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PPARG—pancreatic cancer	3.4e-06	9.02e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTGS2—pancreatic cancer	3.39e-06	9e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.38e-06	8.98e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—APOE—pancreatic cancer	3.38e-06	8.97e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—STK11—pancreatic cancer	3.36e-06	8.92e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MMP9—pancreatic cancer	3.36e-06	8.91e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PTEN—pancreatic cancer	3.34e-06	8.86e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	3.27e-06	8.68e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—AKT1—pancreatic cancer	3.26e-06	8.64e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTEN—pancreatic cancer	3.23e-06	8.56e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—EGFR—pancreatic cancer	3.22e-06	8.54e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PIK3CA—pancreatic cancer	3.22e-06	8.53e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.2e-06	8.49e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	3.17e-06	8.4e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	3.16e-06	8.37e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.16e-06	8.37e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.13e-06	8.29e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CB—pancreatic cancer	3.12e-06	8.27e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CD—pancreatic cancer	3.11e-06	8.24e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	3.1e-06	8.22e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—SRC—pancreatic cancer	3.1e-06	8.21e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	3.09e-06	8.2e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.08e-06	8.16e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	3.05e-06	8.09e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—KRAS—pancreatic cancer	3.04e-06	8.07e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—APOE—pancreatic cancer	3.02e-06	8.01e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—pancreatic cancer	3.02e-06	8e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CXCL8—pancreatic cancer	3e-06	7.95e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—STAT3—pancreatic cancer	2.99e-06	7.92e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NRAS—pancreatic cancer	2.98e-06	7.9e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HRAS—pancreatic cancer	2.98e-06	7.9e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTEN—pancreatic cancer	2.96e-06	7.85e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.95e-06	7.81e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	2.89e-06	7.68e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.89e-06	7.67e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CD44—pancreatic cancer	2.88e-06	7.63e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	2.87e-06	7.61e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.86e-06	7.58e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.84e-06	7.53e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.79e-06	7.41e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	2.79e-06	7.4e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—APOE—pancreatic cancer	2.78e-06	7.36e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MYC—pancreatic cancer	2.78e-06	7.36e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TGFB1—pancreatic cancer	2.77e-06	7.34e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	2.76e-06	7.33e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	2.76e-06	7.33e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GCG—pancreatic cancer	2.76e-06	7.32e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—APOE—pancreatic cancer	2.75e-06	7.3e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	2.75e-06	7.3e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—pancreatic cancer	2.74e-06	7.26e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.72e-06	7.22e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EGFR—pancreatic cancer	2.71e-06	7.2e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	2.71e-06	7.19e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	2.71e-06	7.18e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	2.7e-06	7.16e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	2.69e-06	7.15e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.68e-06	7.12e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—pancreatic cancer	2.68e-06	7.1e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	2.64e-06	7.01e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.63e-06	6.97e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	2.63e-06	6.97e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	2.63e-06	6.97e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.61e-06	6.91e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	2.6e-06	6.9e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—STK11—pancreatic cancer	2.59e-06	6.88e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	2.59e-06	6.86e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	2.56e-06	6.8e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	2.55e-06	6.78e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CASP3—pancreatic cancer	2.53e-06	6.71e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	2.51e-06	6.67e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.51e-06	6.65e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SRC—pancreatic cancer	2.5e-06	6.63e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	2.49e-06	6.61e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.48e-06	6.59e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCND1—pancreatic cancer	2.46e-06	6.53e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	2.44e-06	6.47e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	2.43e-06	6.45e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	2.42e-06	6.43e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.42e-06	6.41e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	2.41e-06	6.39e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	2.4e-06	6.38e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	2.4e-06	6.37e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.4e-06	6.36e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.39e-06	6.35e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MMP9—pancreatic cancer	2.39e-06	6.34e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTEN—pancreatic cancer	2.39e-06	6.33e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PTEN—pancreatic cancer	2.38e-06	6.31e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	2.36e-06	6.25e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	2.35e-06	6.24e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—APOE—pancreatic cancer	2.35e-06	6.24e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	2.34e-06	6.21e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.34e-06	6.2e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTEN—pancreatic cancer	2.33e-06	6.19e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	2.32e-06	6.15e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.32e-06	6.15e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	2.28e-06	6.05e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—pancreatic cancer	2.28e-06	6.05e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	2.28e-06	6.04e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MYC—pancreatic cancer	2.24e-06	5.94e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	2.23e-06	5.92e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.23e-06	5.92e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.23e-06	5.9e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SRC—pancreatic cancer	2.21e-06	5.85e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.2e-06	5.84e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	2.19e-06	5.81e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.18e-06	5.79e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	2.18e-06	5.78e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SRC—pancreatic cancer	2.17e-06	5.76e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	2.15e-06	5.7e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—STAT3—pancreatic cancer	2.13e-06	5.64e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.12e-06	5.63e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NRAS—pancreatic cancer	2.12e-06	5.63e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	2.11e-06	5.61e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	2.09e-06	5.55e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	2.09e-06	5.54e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.09e-06	5.54e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	2.09e-06	5.54e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	2.07e-06	5.49e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.07e-06	5.49e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.05e-06	5.43e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.02e-06	5.36e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MYC—pancreatic cancer	1.98e-06	5.24e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	1.97e-06	5.23e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MYC—pancreatic cancer	1.94e-06	5.16e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	1.94e-06	5.14e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EGFR—pancreatic cancer	1.93e-06	5.13e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	1.92e-06	5.11e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.92e-06	5.09e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.9e-06	5.05e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.9e-06	5.05e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	1.9e-06	5.04e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.9e-06	5.04e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.89e-06	5e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.87e-06	4.95e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—AKT1—pancreatic cancer	1.86e-06	4.93e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—pancreatic cancer	1.84e-06	4.88e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KRAS—pancreatic cancer	1.83e-06	4.84e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOE—pancreatic cancer	1.82e-06	4.81e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.8e-06	4.78e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	1.8e-06	4.77e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	1.76e-06	4.66e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—AKT1—pancreatic cancer	1.7e-06	4.52e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	1.68e-06	4.47e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	1.68e-06	4.45e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.66e-06	4.4e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.65e-06	4.38e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	1.65e-06	4.37e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.64e-06	4.36e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.64e-06	4.34e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.63e-06	4.31e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—pancreatic cancer	1.62e-06	4.3e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.61e-06	4.27e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—pancreatic cancer	1.6e-06	4.24e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.58e-06	4.19e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	1.55e-06	4.12e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HRAS—pancreatic cancer	1.55e-06	4.12e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	1.53e-06	4.05e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.44e-06	3.82e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.43e-06	3.78e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.41e-06	3.73e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.38e-06	3.65e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT1—pancreatic cancer	1.37e-06	3.63e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	1.35e-06	3.58e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.34e-06	3.57e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.27e-06	3.37e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.26e-06	3.33e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.24e-06	3.3e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.17e-06	3.1e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.16e-06	3.09e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.16e-06	3.08e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.08e-06	2.88e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.04e-06	2.76e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	9.91e-07	2.63e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKT1—pancreatic cancer	9.56e-07	2.54e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKT1—pancreatic cancer	9.48e-07	2.51e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKT1—pancreatic cancer	8.1e-07	2.15e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	7.65e-07	2.03e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.25e-07	1.66e-05	CbGpPWpGaD
